AbbVie
ABBV
#25
Rank
ยฃ297.62 B
Marketcap
ยฃ168.40
Share price
0.98%
Change (1 day)
25.88%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ100.13 Billion

According to AbbVie's latest financial reports the company's total assets are ยฃ100.13 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ107.70 B1.86%
2023-12-31ยฃ105.73 B-7.84%
2022-12-31ยฃ114.73 B5.69%
2021-12-31ยฃ108.55 B-1.73%
2020-12-31ยฃ110.46 B62.54%
2019-12-31ยฃ67.95 B45.34%
2018-12-31ยฃ46.75 B-10.73%
2017-12-31ยฃ52.37 B-2.23%
2016-12-31ยฃ53.56 B49.64%
2015-12-31ยฃ35.79 B102.57%
2014-12-31ยฃ17.67 B-0.17%
2013-12-31ยฃ17.70 B5.93%
2012-12-31ยฃ16.70 B33.05%
2011-12-31ยฃ12.55 B-8.26%
2010-12-31ยฃ13.69 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ156.09 B 55.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ72.45 B-27.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ85.95 B-14.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ67.41 B-32.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ43.77 B-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ21.84 B-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ61.66 B-38.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
ยฃ85.59 B-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ3.19 B-96.81%๐Ÿ‡บ๐Ÿ‡ธ USA